Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G ROSENBLUM

Showing results (61-70 of 243) with videos related to

Pageof 25
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1987
Comparative clinical pharmacology of [111In]-labeled murine monoclonal antibodiesM G Rosenblum, J L Murray, L Lamki, et al.
Cancer Research|January 9, 2003
Immunotoxin resistance in multidrug resistant cellsMelissa S McGrath, Michael G Rosenblum, Mark R Philips, et al.
The Journal of Reproductive Medicine|November 15, 2000
Primary, localized vulvar B-cell lymphoma expressing CD44 variant 6 but not cadherins. A case reportK A Iczkowski, A C Han, M I Edelson, et al.
Gynecologic Oncology|March 27, 2001
Uterine papillary serous carcinoma presenting as distant lymph node metastasisJ S Ng, A C Han, M I Edelson, et al.
The Journal of Investigative Dermatology|November 1, 1983
Percutaneous penetration of methylglyoxal bis(guanylhydrazone): effects on hairless mouse epidermis in vivoJ L McCullough, G D Weinstein, M G Rosenblum, et al.
The Journal of Biological Chemistry|December 5, 1989
Tumor necrosis factor modulates epidermal growth factor receptor phosphorylation and kinase activity in human tumor cells. Correlation with cytotoxicityN J Donato, G E Gallick, P A Steck, et al.
Methods in Enzymology|January 3, 2012
Cell-targeting fusion constructs containing recombinant geloninMi-Ae Lyu, Yu Joshua Cao, Khalid A Mohamedali, et al.
The Journal of Biological Chemistry|December 9, 2010
Convergent potency of internalized gelonin immunotoxins across varied cell lines, antigens, and targeting moietiesChristopher M Pirie, Benjamin J Hackel, Michael G Rosenblum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
Phase I study of recombinant human interleukin-3 in patients with bone marrow failureR Kurzrock, M Talpaz, Z Estrov, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 17, 2003
Oncoprotein profiles of primary peritoneal malignant mixed müllerian tumorsJ S Ng, A C Han, M I Edelson, et al.
Pageof 25

Showing results (61-70 of 243) with videos related to

Sort By:
Pageof 25
Cancer Chemotherapy and Pharmacology|January 1, 1987
Comparative clinical pharmacology of [111In]-labeled murine monoclonal antibodiesM G Rosenblum, J L Murray, L Lamki, et al.
Cancer Research|January 9, 2003
Immunotoxin resistance in multidrug resistant cellsMelissa S McGrath, Michael G Rosenblum, Mark R Philips, et al.
The Journal of Reproductive Medicine|November 15, 2000
Primary, localized vulvar B-cell lymphoma expressing CD44 variant 6 but not cadherins. A case reportK A Iczkowski, A C Han, M I Edelson, et al.
Gynecologic Oncology|March 27, 2001
Uterine papillary serous carcinoma presenting as distant lymph node metastasisJ S Ng, A C Han, M I Edelson, et al.
The Journal of Investigative Dermatology|November 1, 1983
Percutaneous penetration of methylglyoxal bis(guanylhydrazone): effects on hairless mouse epidermis in vivoJ L McCullough, G D Weinstein, M G Rosenblum, et al.
The Journal of Biological Chemistry|December 5, 1989
Tumor necrosis factor modulates epidermal growth factor receptor phosphorylation and kinase activity in human tumor cells. Correlation with cytotoxicityN J Donato, G E Gallick, P A Steck, et al.
Methods in Enzymology|January 3, 2012
Cell-targeting fusion constructs containing recombinant geloninMi-Ae Lyu, Yu Joshua Cao, Khalid A Mohamedali, et al.
The Journal of Biological Chemistry|December 9, 2010
Convergent potency of internalized gelonin immunotoxins across varied cell lines, antigens, and targeting moietiesChristopher M Pirie, Benjamin J Hackel, Michael G Rosenblum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
Phase I study of recombinant human interleukin-3 in patients with bone marrow failureR Kurzrock, M Talpaz, Z Estrov, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 17, 2003
Oncoprotein profiles of primary peritoneal malignant mixed müllerian tumorsJ S Ng, A C Han, M I Edelson, et al.
Pageof 25